Ramiven 150mg (Abemaciclib Tablet) 150mg

Ramiven 150mg (Abemaciclib) is an oral tablet used in cancer therapy. This 150mg strength medication is prescribed to slow disease progression in certain breast cancers. Store at room temperature and keep out of reach of children. Not intended for self-medication.

Strength

150mg

Pack Size

14s

Storage

Ambient

Manufacturer / TM Owner

Lilly S.A

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Abemaciclib 150mg is primarily used to treat hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. It works by inhibiting specific proteins that drive cancer cell growth. This medication is often prescribed alongside hormone therapy for postmenopausal women. Patients may wonder what is abemaciclib used for and whether it’s suitable for their condition.

Side Effects

Patients taking Ramiven 150mg may experience changes in energy levels, digestive effects, or temporary hair thinning. Some report mild nausea or appetite changes during treatment. These effects vary by individual and are typically monitored by a healthcare provider. Consistent use as directed is important for effectiveness.

Precautions & Warnings

Keep Ramiven 150mg in its original packaging at room temperature, away from moisture and heat. Avoid crushing or splitting tablets unless instructed by a doctor. Inform your healthcare provider about all medications and supplements you’re taking. Store securely to prevent accidental ingestion by children or pets.

Avoid Interactions

Abemaciclib may interact with strong CYP3A inhibitors or inducers, altering its effectiveness. Grapefruit products can affect how the body processes this medication. Certain herbal supplements and over-the-counter drugs may also pose risks. Always discuss potential interactions with your doctor before starting or stopping any medication.

References

Frequently Asked Questions

Abemaciclib 150mg is used to treat certain types of advanced or metastatic breast cancer in adults.

Store Ramiven 150mg at room temperature in a dry place, away from direct light and out of reach of children.

Some medications may interact with abemaciclib; consult your healthcare provider before combining treatments.

Common effects may include fatigue, nausea, or changes in appetite; report persistent issues to your doctor.

Abemaciclib is a targeted therapy, not a traditional chemotherapy agent.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.